Monitoring non-fatal overdose events from EMS data may aid in developing emergency response.
Cumulative incidence of opioid-related adverse events was 38.3 per 100,000 prescriptions.
Variation exists in opioid prescribing practices among clinicians in single-hospital systems, which prompts concern about the potential for opioid overprescribing.
Odds of pre-op opioid use up with age 31 to 40 years, tobacco use, illicit drug use, depression.
American emergency medicine physicians have been taking measures to address the ongoing opioid crisis, which affects emergency departments throughout the country.
History of involvement with criminal justice system increased with intensity of drug use.
Consensus guidelines regarding the use of ketamine for the management of acute pain have been approved.
Surgeon General Jerome M. Adams, M.D., M.P.H., has urged more Americans to carry naloxone, an FDA-approved medication that can be delivered via nasal mist or injection and can temporarily suspend the effects of opioid overdose.
A panel discussion event held at the US Food and Drug Administration gathered patients with chronic pain and FDA officials, to reconcile concerns around prescriptions of opioid medications with the needs of these patient populations.
Women prescribed long- vs short-term opioids for chronic musculoskeletal pain may be at increased risk for menopause and abnormal menstruation.
In adults with sickle cell disease, higher daily opioid use may be associated with poorer health-related quality of life.
Lofexidine may help patients with opioid withdrawal symptoms or difficulty with opioid discontinuation.
Researchers deployed a survey to individuals who had received treatment for opioid use disorder to assess their use of buprenorphine.
Investigators assessed the potential for abuse associated with NKTR-181, a new mu-opioid receptor agonist analgesic.
A combination of naltrexone induction and psychoeducational counseling was found to facilitate transition from active opioid use and buprenorphine maintenance in individuals with opioid use disorder.
With the increasing number of patients presenting to surgery with opioid tolerance, clinicians should be familiar with their specific analgesic needs.
Minority of opioid overdose survivors receive MOUD; buprenorphine, MMT linked to reduced mortality
In patients receiving opioid substitution treatment for opioid use disorder (mainly involving heroin), those exhibiting a rapid decline in heroin use were found to be more likely to have successful treatment outcomes.
Electrical pulses are sent through small needles that are inserted in the ear to combat the early stages of detoxification, leading to stabilization.
From 2011 to 2016, increase in invasive MRSA cases from 4.1 to 9.2 percent among injection drug users.
The U.S. Food and Drug Administration has issued warnings to 9 online companies selling illegal opioid medications on 53 websites, in direct violation of the Federal Food, Drug, and Cosmetic Act.
Burden of deaths up; most patients receiving opioid analgesics use immediate-release formulations
Lucemyra is an oral selective alpha 2-adrenergic receptor agonist
Payments correlated with prescribing opioids in 2014 may have influenced the increased prescription rates of 2015.
PA students perceived improved confidence in their ability to provide patient education and counseling.
Opioid-specific health seminars may help PA students learn lifesaving treatments to perform in the future.
Many patients reported unsafe storage and failure to dispose of opioids at one- and 6-month follow-up
Relative decrease in buprenorphine-naloxone exposure after transition to unit-dose packaging
From 2010 to 2016, synthetic opioid involvement up from 14.3 to 45.9% of opioid-related deaths
Based on data from multiple sources, many opioid-overdose deaths seem to be suicides